Alife

formerly Alife Health

IVF powered by artificial intelligence

San Francisco, United States · Founded 2020 · $31.5M raised

Employees
51–200
Founded
2020
Business Model
B2B2C
Total Funding
$31.5M
Last Round
$22.0M Series AMar 2022
Rounds
2

About

Alife Health is an AI-powered fertility technology company modernizing the IVF process with cutting-edge clinical tools designed to improve outcomes and reduce costs. Its flagship product, Embryo Predict — FDA-cleared in 2026 — provides labs with consistent, objective AI embryo scoring to aid in every transfer decision. The platform also includes Schedule Predict, which reduces over-capacity retrieval days by up to 65%, and Success Predictor, which increases patient conversion by more than 3%. Alife's technology is trusted by leading fertility networks including US Fertility, Inception Fertility, Shady Grove Fertility, and RSC Bay Area.

Summary

Alife is an Artificial Intelligence company based in San Francisco, United States, founded in 2020. It has raised $31.5M in total across 2 rounds, most recently a $22.0M Series A round in Mar 2022. Investors include Lux Capital, Union Square Ventures and Amplo.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AMar 2022
$22.0M

Sign up to see all 2 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Alife on Indexed.vc
<a href="https://indexed.vc/companies/alife"><img src="https://indexed.vc/api/badge/company/alife" alt="Alife on Indexed.vc" width="260" height="76" /></a>